Soft tissue sarcoma is a rare but aggressive cancer that can affect muscles, fat, blood vessels, or connective tissues. India provides advanced surgical, chemotherapeutic, and radiation options at a cost of $4,500–$9,000 USD, compared to $30,000–$70,000 in the USA and $18,000–$25,000 in Thailand. With experienced oncologists like Dr. Ankur Bahl, foreign patients benefit from global-standard treatment and personalized care at a fraction of the cost.
Soft tissue sarcoma (STS) is a rare group of cancers that originate in the soft tissues of the body—such as muscles, fat, nerves, blood vessels, and connective tissues. It can occur anywhere in the body but is most commonly found in the arms, legs, and abdomen.
There are over 50 subtypes of soft tissue sarcoma, making accurate diagnosis and tailored treatment crucial for effective care.
While the exact cause is often unknown, certain factors increase the risk of developing soft tissue sarcoma.
STS can occur at any age but is more frequent in adults over 40 and in children with specific inherited conditions.
Soft tissue sarcoma includes a wide range of subtypes, each with different growth patterns and treatment responses.
Each type requires a personalized treatment plan based on pathology and genetic testing.
Symptoms depend on tumor size, location, and growth rate. Many patients initially mistake sarcoma for a benign lump or swelling.
Early diagnosis significantly improves treatment outcomes.
India provides fast, accurate, and cost-effective diagnostics for STS using global-standard techniques.
Diagnosis is typically completed within 3–5 days, allowing patients to begin timely treatment.
India provides a full spectrum of advanced treatment options for soft tissue sarcoma, guided by a multidisciplinary team of surgical oncologists, medical oncologists, radiation specialists, and pathologists.
Surgery
Radiation Therapy
Chemotherapy
Targeted Therapy
Palliative Care
Indian cancer centers follow global protocols such as NCCN, ESMO, and ASCO guidelines, while personalizing treatment based on tumor type, grade, and patient profile.
Treatment plans are reviewed in tumor board meetings to ensure collaborative decision-making.
India is globally recognized for offering world-class cancer care at an accessible price, with a full suite of diagnostic, surgical, and medical services.
Dr. Ankur Bahl is one of India’s leading medical oncologists, known for his expertise in managing rare and aggressive cancers like soft tissue sarcomas.
Dr. Bahl’s focus is on accuracy, ethics, and compassionate care, making him a trusted name in global oncology.
India’s cancer hospitals use cutting-edge diagnostic and treatment technologies that match those available in top international centers.
These technologies ensure maximum tumor control with minimal side effects, especially important in preserving limb function and quality of life.
India offers highly affordable yet advanced sarcoma care. Costs vary depending on cancer type, treatment complexity, and hospital.
Treatment Component |
Estimated Cost |
Diagnostics (imaging, biopsy, labs) |
$600 – $1,000 |
Surgery (limb-sparing or major) |
$2,000 – $4,500 |
Chemotherapy (multiple cycles) |
$1,500 – $2,500 |
Radiation Therapy (if needed) |
$1,000 – $2,000 |
Targeted Therapy (if applicable) |
$2,000 – $3,000 |
Hospital Stay & Follow-Up |
$500 – $1,000 |
Total Cost Range |
$4,500 – $9,000+ |
Actual pricing depends on the cancer subtype, number of sessions, and drug regimen.
India provides global-standard sarcoma care at a fraction of the cost in Western and Southeast Asian nations.
Country |
Average Cost |
India |
$4,500 – $9,000 |
USA |
$30,000 – $70,000 |
Thailand |
$18,000 – $25,000 |
UK |
$35,000 – $60,000 |
Singapore |
$40,000 – $65,000 |
India offers 60–80% cost savings while maintaining the same clinical and surgical excellence.
Day 1–3: Consultation + PET-CT + Biopsy
Day 4–6: Tumor board review + Treatment plan
Day 7–14: Surgery (if operable)
Weeks 3–8: Chemotherapy/Radiation (as needed)
Week 9+: Follow-up scans and discharge
Surgery Recovery: 10–20 days (limb-sparing)
Chemotherapy Cycles: 3–6 weeks (outpatient or inpatient)
Radiation: 3–5 weeks
Total stay for foreign patients: 2–6 weeks, depending on treatment type.
Side effects vary based on the chosen modality but are well-managed in Indian oncology centers.
India’s hospitals include nutritionists, physiotherapists, and palliative care specialists to minimize discomfort and boost recovery.
India welcomes medical travelers from around the world with a clear and organized process.
The hospital will issue a visa invitation letter and support your travel arrangements, accommodation, and airport pickup.
Dr. Ankur Bahl is a renowned medical oncologist with a track record of treating complex sarcoma cases from across the world. Starting your treatment under his care is a straightforward, well-supported process.
Email medical records – Send your biopsy reports, PET-CT scans, and previous treatment summaries.
Schedule a video consultation – Dr. Bahl will assess your case and provide a recommended treatment plan.
Get a treatment estimate and visa letter – Receive a cost breakdown and a formal invitation letter from the hospital.
Apply for your medical visa – Use the invitation to obtain your visa at the Indian consulate.
Travel to India and begin treatment – All appointments and logistics are pre-arranged by the hospital's international desk.
Post-treatment follow-ups – Can be managed via teleconsultation after returning to your home country.
His team assists with every detail—airport pickup, accommodation, interpreters, and post-treatment coordination.
Soft tissue sarcoma is a rare but treatable form of cancer—timing, technology, and expert care are critical. India offers a unique advantage by providing world-class care at a fraction of global costs, and Dr. Ankur Bahl is among the most trusted names in sarcoma oncology.
Start Now:
If you or a loved one is facing soft tissue sarcoma, don’t delay. Email your reports today for an expert opinion from Dr. Ankur Bahl and begin your journey toward affordable, expert-led treatment in India.
Experience global-standard cancer care—with compassion and precision—in India.
Soft tissue sarcoma is a group of rare cancers that develop in the connective tissues—such as muscles, fat, nerves, or blood vessels. It can occur anywhere in the body and requires specialized, multidisciplinary care
Yes, especially if diagnosed early. Surgery, often combined with radiation or chemotherapy, offers a high success rate. Even advanced cases can be managed effectively with targeted therapies and systemic treatments.
The total treatment cost typically ranges from $4,500 to $9,000 USD, including surgery, chemotherapy, diagnostics, and hospital stay. This is significantly more affordable compared to treatment in the US or Europe.
India offers limb-sparing surgery, radiation therapy, chemotherapy, and advanced targeted treatments. Treatment is tailored to the sarcoma type, stage, and patient health condition.
Yes. International patients can have an online video consultation with Dr. Bahl, who will review reports and provide a personalized treatment plan along with a cost estimate.
Most patients stay for 2 to 6 weeks, depending on surgery type, post-operative care, and whether chemotherapy or radiation is required. Follow-up can be continued online after returning home.
You will need a valid passport, medical visa, biopsy/imaging reports, and previous treatment history. The hospital will provide a visa invitation letter and assist with logistics like airport pickup and accommodation.